Skip to main content
Top
Published in: Journal of Endocrinological Investigation 10/2017

Open Access 01-10-2017 | Original Article

Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells

Authors: C. Antinozzi, F. Marampon, C. Corinaldesi, E. Vicini, P. Sgrò, G. B. Vannelli, A. Lenzi, C. Crescioli, L. Di Luigi

Published in: Journal of Endocrinological Investigation | Issue 10/2017

Login to get access

Abstract

Purpose

Testosterone by promoting different metabolic pathways contributes to short-term homeostasis of skeletal muscle, the largest insulin-sensitive tissue and the primary site for insulin-stimulated glucose utilization. Despite evidences indicate a close relationship between testosterone and glucose metabolism, the molecular mechanisms responsible for a possible testosterone-mediated insulin-like effects on skeletal muscle are still unknown.

Methods

Here we used undifferentiated proliferating or differentiated human fetal skeletal muscle cells (Hfsmc) to investigate the short-term effects of testosterone on the insulin-mediated biomolecular metabolic machinery. GLUT4 cell expression, localization and the phosphorylation/activation of AKT, ERK, mTOR and GSK3β insulin-related pathways at different time points after treatment with testosterone were analyzed.

Results

Independently from cells differentiation status, testosterone, with an insulin-like effect, induced Glut4-mRNA expression, GLUT4 protein translocation to the cytoplasmic membrane, while no effect was observed on GLUT4 protein expression levels. Furthermore, testosterone treatment modulated the insulin-dependent signal transduction pathways inducing a rapid and persistent activation of AKT, ERK and mTOR, and a transient inhibition of GSK3β. T-related effects were shown to be androgen receptor dependent.

Conclusion

All together our data indicate that testosterone through the activation of non-genomic pathways, participates in skeletal muscle glucose metabolism by inducing insulin-related effects.
Literature
1.
2.
go back to reference Rahman F et al (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18(10):371–378CrossRefPubMed Rahman F et al (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18(10):371–378CrossRefPubMed
4.
go back to reference Sgrò P et al (2014) Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis. J Endocrinol Investig 37(1):13–24CrossRef Sgrò P et al (2014) Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis. J Endocrinol Investig 37(1):13–24CrossRef
5.
go back to reference Brunelli A et al (2012) Acute exercise modulates BDNF and pro-BDNF protein content in immune cells. Med Sci Sports Exerc 44(10):1871–1880CrossRefPubMed Brunelli A et al (2012) Acute exercise modulates BDNF and pro-BDNF protein content in immune cells. Med Sci Sports Exerc 44(10):1871–1880CrossRefPubMed
6.
go back to reference Peake JM et al (2015) Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. Exerc Immunol Rev 21:8–25PubMed Peake JM et al (2015) Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. Exerc Immunol Rev 21:8–25PubMed
7.
go back to reference Argilés JM et al (2016) Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J Am Med Dir Assoc 17(9):789–796CrossRefPubMed Argilés JM et al (2016) Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J Am Med Dir Assoc 17(9):789–796CrossRefPubMed
8.
go back to reference Kowalski GM et al (2014) The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. Am J Physiol Endocrinol Metab 307(10):E859–E871CrossRefPubMed Kowalski GM et al (2014) The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. Am J Physiol Endocrinol Metab 307(10):E859–E871CrossRefPubMed
9.
go back to reference Mitsuhashi K et al (2016) Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes. Endocrine 51(1):174–184CrossRefPubMed Mitsuhashi K et al (2016) Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes. Endocrine 51(1):174–184CrossRefPubMed
10.
go back to reference Wilson C et al (2013) Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes. J Cell Physiol 228(12):2399–2407CrossRefPubMed Wilson C et al (2013) Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes. J Cell Physiol 228(12):2399–2407CrossRefPubMed
11.
go back to reference Sato K et al (2008) Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab 294(5):E961–E968CrossRefPubMed Sato K et al (2008) Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab 294(5):E961–E968CrossRefPubMed
12.
go back to reference Ahtiainen JP et al (2011) Recovery after heavy resistance exercise and skeletal muscle androgen receptor and insulin-like growth factor-I isoform expression in strength trained men. J Strength Cond Res 25(3):767–777CrossRefPubMed Ahtiainen JP et al (2011) Recovery after heavy resistance exercise and skeletal muscle androgen receptor and insulin-like growth factor-I isoform expression in strength trained men. J Strength Cond Res 25(3):767–777CrossRefPubMed
13.
go back to reference Crescioli C et al (2012) Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 91:139–149CrossRefPubMed Crescioli C et al (2012) Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 91:139–149CrossRefPubMed
15.
go back to reference Gallina P et al (2008) Development of human striatal anlagen after transplantation in a patient with Huntington’s disease. Exp Neurol 213(1):241–244CrossRefPubMed Gallina P et al (2008) Development of human striatal anlagen after transplantation in a patient with Huntington’s disease. Exp Neurol 213(1):241–244CrossRefPubMed
16.
go back to reference Vulcano F et al (2006) HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. Exp Cell Res 312(9):1590–1597CrossRefPubMed Vulcano F et al (2006) HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. Exp Cell Res 312(9):1590–1597CrossRefPubMed
17.
go back to reference Crescioli C et al (2013) Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. J Endocrinol Investig 36(11):1020–1026 Crescioli C et al (2013) Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. J Endocrinol Investig 36(11):1020–1026
18.
go back to reference Marchiani S et al (2006) The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. J Cancer Res Clin Oncol 132(6):408–416CrossRefPubMed Marchiani S et al (2006) The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. J Cancer Res Clin Oncol 132(6):408–416CrossRefPubMed
19.
go back to reference Gravina GL et al (2013) PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. Endocr Relat Cancer 20(3):321–337CrossRefPubMed Gravina GL et al (2013) PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. Endocr Relat Cancer 20(3):321–337CrossRefPubMed
20.
go back to reference Karstoft K et al (2016) Skeletal muscle as a gene regulatory endocrine organ. Curr Opin Clin Nutr Metab Care 19(4):270–275CrossRefPubMed Karstoft K et al (2016) Skeletal muscle as a gene regulatory endocrine organ. Curr Opin Clin Nutr Metab Care 19(4):270–275CrossRefPubMed
22.
go back to reference Dimitriadis G et al (2011) Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 93(Suppl 1):S52–S59CrossRefPubMed Dimitriadis G et al (2011) Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 93(Suppl 1):S52–S59CrossRefPubMed
23.
go back to reference Herbst KL et al (2004) Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 7(3):271–277CrossRefPubMed Herbst KL et al (2004) Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 7(3):271–277CrossRefPubMed
24.
go back to reference Blaya R et al (2016) Total testosterone levels are correlated to metabolic syndrome components. Aging Male 19(2):85–89CrossRefPubMed Blaya R et al (2016) Total testosterone levels are correlated to metabolic syndrome components. Aging Male 19(2):85–89CrossRefPubMed
25.
go back to reference Rotter I et al (2015) Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men. Aging Male 18(4):249–255CrossRefPubMed Rotter I et al (2015) Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men. Aging Male 18(4):249–255CrossRefPubMed
26.
go back to reference Legro RS et al (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84(1):165–169PubMed Legro RS et al (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84(1):165–169PubMed
27.
go back to reference Isidori AM et al (2015) Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Investig 38(1):103–112CrossRef Isidori AM et al (2015) Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Investig 38(1):103–112CrossRef
28.
go back to reference Dhindsa S et al (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89(11):5462–5468CrossRefPubMed Dhindsa S et al (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89(11):5462–5468CrossRefPubMed
30.
go back to reference Leto D et al (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13(6):383–396CrossRefPubMed Leto D et al (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13(6):383–396CrossRefPubMed
31.
go back to reference Flores-Riveros JR et al (1993) Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci USA 90(2):512–516CrossRefPubMedPubMedCentral Flores-Riveros JR et al (1993) Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci USA 90(2):512–516CrossRefPubMedPubMedCentral
32.
go back to reference Yu ZW et al (2001) Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose–potential implications for insulin resistance. Biochim Biophys Acta. 1535(2):174–185CrossRefPubMed Yu ZW et al (2001) Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose–potential implications for insulin resistance. Biochim Biophys Acta. 1535(2):174–185CrossRefPubMed
33.
go back to reference Thorens B et al (2010) Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298(2):E141–E145CrossRefPubMed Thorens B et al (2010) Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298(2):E141–E145CrossRefPubMed
34.
35.
go back to reference Klepper J et al (2002) Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain—a review. Eur J Pediatr 161(6):295–304CrossRefPubMed Klepper J et al (2002) Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain—a review. Eur J Pediatr 161(6):295–304CrossRefPubMed
37.
39.
go back to reference Haruta T et al (1995) Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J Biol Chem. 270(47):27991–27994CrossRefPubMed Haruta T et al (1995) Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J Biol Chem. 270(47):27991–27994CrossRefPubMed
40.
go back to reference Nikoulina SE et al (2002) Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51(7):2190–2198CrossRefPubMed Nikoulina SE et al (2002) Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51(7):2190–2198CrossRefPubMed
41.
go back to reference Watson RT et al (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25(2):177–204CrossRefPubMed Watson RT et al (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25(2):177–204CrossRefPubMed
42.
go back to reference Ma J et al (2014) Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem. 289(1):133–142CrossRefPubMed Ma J et al (2014) Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem. 289(1):133–142CrossRefPubMed
43.
go back to reference Basualto-Alarcón C et al (2013) Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Med Sci Sports Exerc 45(9):1712–1720CrossRefPubMed Basualto-Alarcón C et al (2013) Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Med Sci Sports Exerc 45(9):1712–1720CrossRefPubMed
44.
go back to reference Lee WJ (2009) Insulin-like growth factor-I-induced androgen receptor activation is mediated by the PI3K/Akt pathway in C2C12 skeletal muscle cells. Mol Cells 28(5):495–499CrossRefPubMed Lee WJ (2009) Insulin-like growth factor-I-induced androgen receptor activation is mediated by the PI3K/Akt pathway in C2C12 skeletal muscle cells. Mol Cells 28(5):495–499CrossRefPubMed
45.
go back to reference Di Luigi L et al (2003) Heredity and pituitary response to exercise-related stress in trained men. Int J Sports Med 24(8):551–558CrossRefPubMed Di Luigi L et al (2003) Heredity and pituitary response to exercise-related stress in trained men. Int J Sports Med 24(8):551–558CrossRefPubMed
46.
47.
go back to reference Di Luigi L et al (2005) Androgenic anabolic steroids abuse in males. J Endocrinol Investig 28(3):81–84 Di Luigi L et al (2005) Androgenic anabolic steroids abuse in males. J Endocrinol Investig 28(3):81–84
48.
go back to reference Baldari C et al (2009) Is explosive performance influenced by androgen concentrations in young male soccer players? Br J Sports Med 43(3):191–194CrossRefPubMed Baldari C et al (2009) Is explosive performance influenced by androgen concentrations in young male soccer players? Br J Sports Med 43(3):191–194CrossRefPubMed
49.
go back to reference Di Luigi L et al (2008) The type 5 phosphodiesterase’s inhibitor tadalafil influences salivary cortisol, testosterone and dehydroepiandrosterone sulfate response to maximal exercise in healthy man. J Clin Endocrinol Metab 93(9):3510–3514CrossRefPubMed Di Luigi L et al (2008) The type 5 phosphodiesterase’s inhibitor tadalafil influences salivary cortisol, testosterone and dehydroepiandrosterone sulfate response to maximal exercise in healthy man. J Clin Endocrinol Metab 93(9):3510–3514CrossRefPubMed
50.
go back to reference Di Luigi L et al (2007) Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sport Med 28(10):809–814CrossRef Di Luigi L et al (2007) Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sport Med 28(10):809–814CrossRef
51.
go back to reference Sabatini S, Sgrò P, Duranti G, Ceci R, Di Luigi L (2011) Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochim Pol 58(2):237–242PubMed Sabatini S, Sgrò P, Duranti G, Ceci R, Di Luigi L (2011) Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochim Pol 58(2):237–242PubMed
52.
go back to reference Di Luigi L et al (2008) The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes’ VO2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 29(2):110–115CrossRefPubMed Di Luigi L et al (2008) The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes’ VO2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 29(2):110–115CrossRefPubMed
53.
go back to reference Felici F et al (2016) Acute severe male hypo-testosteronemia affects central motor command in humans. J Electromyogr Kinesiol 28:184–192CrossRefPubMed Felici F et al (2016) Acute severe male hypo-testosteronemia affects central motor command in humans. J Electromyogr Kinesiol 28:184–192CrossRefPubMed
54.
go back to reference Di Luigi L et al (2012) Andrological aspects of physical exercise and sport medicine. Endocrine 42(2):278–284CrossRefPubMed Di Luigi L et al (2012) Andrological aspects of physical exercise and sport medicine. Endocrine 42(2):278–284CrossRefPubMed
Metadata
Title
Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells
Authors
C. Antinozzi
F. Marampon
C. Corinaldesi
E. Vicini
P. Sgrò
G. B. Vannelli
A. Lenzi
C. Crescioli
L. Di Luigi
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 10/2017
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-017-0686-y

Other articles of this Issue 10/2017

Journal of Endocrinological Investigation 10/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.